OverviewChartNewsTraderScreen

BNP Paribas Knock-Out SNW 16.05.2.../  DE000PL3S1Q0  /

Frankfurt Zert./BNP
1/10/2025  6:47:05 PM Chg.+0.430 Bid7:22:53 PM Ask7:22:53 PM Underlying Strike price Expiration date Option type
4.090EUR +11.75% 4.080
Bid Size: 2,451		 4.580
Ask Size: 2,184		 SANOFI SA INHABER ... - EUR 5/16/2025 Call
TeleTrader 12/31/2024 Europe opens year-end session with losses
TeleTrader 11/22/2024 Europe closes higher, FTSE up over 1%
TeleTrader 10/25/2024 Europe closes mixed amid earnings, data
TeleTrader 10/25/2024 Europe lower in premarket as financial results pour in
TeleTrader 10/25/2024 Sanofi's Q3 net sales up by 15.7% to €13.44 billion
TeleTrader 10/21/2024 Sanofi in talks with CD&R for 50% stake in Opella
GlobeNewswire 9/2/2024 Press Release: Tolebrutinib meets primary endpoint in HERCULES phase 3 study, the first and only to ...
GlobeNewswire 8/26/2024 Latest Dupixent® (dupilumab) and Itepekimab Data at ERS Highlight Scientific Innovation and Leadersh...
GlobeNewswire 8/14/2024 Anaptys Announces Pricing of $100 Million Underwritten Registered Direct Offering
GlobeNewswire 8/13/2024 Vigil Neuroscience Reports Second Quarter 2024 Financial Results and Provides Business Update
GlobeNewswire 8/12/2024 MeiraGTx Announces $50 Million Offering of Ordinary Shares led by Sanofi and Reports Second Quarter ...
GlobeNewswire 8/12/2024 MeiraGTx Announces Pricing of Offering of Ordinary Shares Led by Sanofi
GlobeNewswire 8/8/2024 Press Release: Sarclisa induction treatment demonstrated significantly improved progression-free sur...
GlobeNewswire 8/7/2024 Kymera Therapeutics Announces Second Quarter 2024 Financial Results and Provides a Business Update
GlobeNewswire 8/6/2024 Alzheimer's Disease Diagnostics & Therapeutics Market Driven by Use of Biomarkers and Advancing R&D ...
GlobeNewswire 8/5/2024 Fierce Biotech Names Recludix Pharma a “Fierce 15” Biotech Company of 2024
GlobeNewswire 8/2/2024 Madrigal Pharmaceuticals Appoints Shannon Kelley as General Counsel
GlobeNewswire 8/1/2024 Denali Therapeutics Reports Second Quarter 2024 Financial Results and Business Highlights
GlobeNewswire 8/1/2024 Regeneron Reports Second Quarter 2024 Financial and Operating Results
GlobeNewswire 7/31/2024 Fulcrum Therapeutics Announces Recent Business Highlights and Financial Results for Second Quarter 2...
GlobeNewswire 7/25/2024 Press Release: Online availability of Sanofi’s half-year financial report for 2024
TeleTrader 7/25/2024 Europe lower premarket as earnings pour in
TeleTrader 7/25/2024 Sanofi net sales up 7.8% to €10.7B in Q2
GlobeNewswire 7/25/2024 Press Release: Sanofi Q2 - strong performance with 10% sales growth; 2024 guidance upgraded
GlobeNewswire 7/24/2024 US Hematologists Express High Unmet Need in Treatments for Warm Autoimmune Hemolytic Anemia and Cold...